Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Psychiatry
  4. ADHD

ADHD

  • ADHD (60)
    • Natural Medicines/Supplements (4)
    • Treatment (48)
  • Anxiety (28)
  • Bipolar Disorder (9)
  • Depression (241)
  • Mental Health (21)
  • Psychology (2)
  • Resources (124)
  • Schizophrenia (50)
  • Sleep Disorders (81)
  • Substance Use Disorder (175)
16 - 30 of 60 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Weigh the Benefits and Risks of Vyvanse in Binge-Eating Patients December 2016
Commentary: Binge Eating December 2016
Article: Ensure Males Are Informed About Priapism Risk With Methylphenidate June 2015
Commentary: Risk of Priapism with Methylphenidate June 2015
Article: Help Put Suicide Risks With ADHD Meds Into Perspective May 2015
Commentary: ADHD Drugs and the Risk of Suicide May 2015
Article: Suggest Atomoxetine if Methylphenidate Response Is Inadequate April 2015
Commentary: Management of ADHD: When a Stimulant is Not Enough April 2015
Article: Suggest Vyvanse for Adults Who Binge Eat More Than 3 Days Per Week March 2015
Commentary: Binge Eating March 2015
Commentary: Managing ADHD Stimulant Side Effects September 2014
Article: whether ADHD stimulants increase cardiovascular risk in children and adolescents September 2014
Article: whether acetaminophen is risky during pregnancy April 2014
Article: Intuniv XR (in-TOO-niv), a new once-daily extended-release guanfacine for ADHD in kids November 2013
Commentary: ADHD Stimulant FAQs September 2013
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved